Bird & Bird has advised the Dementia Discovery Fund on the deal. The investment will enable Amphista to accelerate the application of its technology into indications...
Amphista Therapeutics’ Series B Extension Investment
AviadoBio’s $80 Million Series A Financing
Bristows advised AviadoBio’s seed investors. AviadoBio raised $80 million in Series A financing to advance neurodegenerative gene therapy platform. AviadoBio is a pioneering gene therapy company focused...